Comparative pupil dilation using phenylephrine alone or in combination with tropicamide

Ophthalmology

Volumn 105, Issue 4, 1998, Pages 726-732

  Eyeson Annan, Margo L ^a   Hirst, Lawrence W ^b   Battistutta, Diana ^c   Green, Adèle ^c  

^a QUEENSLAND HEALTH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MOXISYLYTE; PHENYLEPHRINE; TROPICAMIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CATARACT; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MYDRIASIS; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0031893102     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)94030-1     Document Type: Article

References (38)

1. Leske MC, Sperduto RD. The epidemiology of senile cataracts: a review. Am J Epidemiol 1983;118:152-65.
2. Brilliant LB, Grasset NC, Pokhrel RP, et al. Associations among cataract prevalence, sunlight hours, and altitude in the Himalayas. Am J Epidemiol 1983;118:250-64.
3. Hollows F, Moran D. Cataract-the ultraviolet risk factor. Lancet 1981;2:1249-50.
4. Taylor HR, West S, Muñoz B, et al. The long-term effects of visible light on the eye. Arch Ophthalmol 1992;110:99-104.
5. Green A, Battistutta D, Hart V, et al. The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants. Control Clin Trials 1994;15:512-22.
6. Taylor HR, Livingston PM, Stanislavsky YC, McCarty CA. Visual impairment in Australia: distances visual acuity, near vision, and visual field findings in the Melbourne Visual Impairment Project. Am J Ophthalmol 1997;123:328-37.
7. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
8. Sperduto RD, Seigel D. Senile lens and senile macular changes in a population-based sample. Am J Ophthalmol 1980;90:86-91.
9. Sperduto RD, Hiller R. The prevalence of nuclear, cortical, and posterior subcapsular lens opacities in a general population sample. Ophthalmology 1984;91:815-8.
10. Hu TS, Zhen Q, Sperduto RD, et al. Age-related cataract in the Tibet Eye Study. Arch Ophthalmol 1989;107:666-9.
11. Wang GM, Spector A, Luo CQ, et al. Prevalence of age-related cataract in Ganzi and in Qinpu. The Epidemiological Study Group. Dev Ophthalmol 1991;21:33-40.
12. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology 1992;99:546-52.
13. Das BN, Thompson JR, Patel R, Rosenthal AR. The prevalence of age related cataract in the Asian community in Leicester: a community based study. Eye 1990;4:723-6.
14. Suzuki K, Kato K, Shikano M, Masuhara N. Epidemiological study for cataract in a northern area of Japan. Cataract and its subjective symptom. Dev Ophthalmol 1991;21:41-5.
15. Yamamoto A, Yata K, Fujiwara T, et al. Investigation of cataract risk factors with retro-illumination photography II. Dev Ophthalmol 1991;21:91-6.
16. Maraini G, Pasquini P, Tomba MC, et al. An independent evaluation of the lens opacities classification system II (LOCS II). Ophthalmology 1989;96:611-5.
17. Zainuddin D, Sasaki K, Kojima M, et al. Risk factor analysis in a cataract epidemiological survey in West Sumatra, Indonesia. Dev Ophthalmol 1991;21:78-86.
18. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts (published erratum appears in Arch Ophthalmol 1989;107:1288). Arch Ophthalmol 1989;107:670-6.
19. Shyn KH, Kim JC, Kim IS, Lee YH. Epidemiology of cataract in outpatient clinics. Dev Ophthalmol 1991;21:23-7.
20. Vassileva P, Parvova-Djurova T, Parvanov G. Prevalence of lens opacities in a population-based survey in Sofia District: a preliminary report. Dev Ophthalmol 1991;21:49-54.
21. Barlet JD. Administration of and adverse reactions to cycloplegic agents. Am J Optom Physiol Opt 1978;55:227-33.
22. Cody RP, Smith JK. Applied statistics and the SAS programming language, 3rd ed. New York: North-Holland, 1991.
23. Brown NA, Brown AJ, Ayliffe W, et al. The objective assessment of cataract. Eye 1987;1(Pt 2):234-46.
24. Taylor HR, West SK. The clinical grading of lens opacities. Aust N Z J Ophthalmol 1989;17:81-6.
25. Pollack SL, Hunt JS, Polse KA. Dose-response effects of tropicamide HCl. Am J Optom Physiol Opt 1981;58:361-6.
26. Montgomery DM, MacEwan CJ. Pupil dilatation with tropicamide. The effects on acuity accommodation and refraction. Eye 1989;3:845-8.
27. Goder GJ, Huebscher HJ. Contribution to the improvement of epidemiological cataract classification. Dev Ophthalmol 1991;21:115-9.
28. Taylor HR, Munoz B. The incidence and progression of lens opacities. Aust N Z J Ophthalmol 1991;19:351-6.
29. Saheb NE, Lorenzetti D, East D, Salpeter-Carlton S. Thymoxamine versus pilocarpine in the reversal of phenylephrine-induced mydriasis. Can J Ophthalmol 1982;17:266-7.
30. Grehn F, Fleig T, Schwarzmuller E. Thymoxamine: a miotic for intraocular use. Graefes Arch Clin Exp Ophthalmol 1986;224:174-8.
31. Mapstone R. Safe mydriasis. Br J Ophthalmol 1970; 54:690-2.
32. Levine L. Mydriatic effectiveness of dilute combinations of phenylephrine and tropicamide. Am J Optom Physiol Opt 1982;59:580-94.
33. Shah B, Hubbard B, Stewart-Jones JH, et al. Influence of thymoxamine eye-drops on the mydriatic effect of tropicamide and phenylephrine alone and in combination. Ophthalmic Physiol Opt 1989;9:153-5.
34. Bellucci R, Tovena G, Marraffa M. Utilita practica del colliro di dapiprazolo nella reversione della midriasi diagnositica. Boll Ocul 1988;67(Suppl 3):281-6.
35. Siegel BS, Thompson AK, Yolton DP, et al. A comparison of diagnostic outcomes with and without pupillary dilatation. J Am Optom Assoc 1990;61:25-34.
36. Wright MM, Skuta GL, Drake MV, et al. Time course of thymoxamine reversal of phenylephrine-induced mydriasis. Arch Ophthalmol 1990;108:1729-32.
37. Nelson ME, Orton HP. Counteracting the effects of mydriatics. Does it benefit the patient? Arch Ophthalmol 1987;105:486-9.
38. Mohan M. Cataract prevalence study-an Indian experience. Dev Ophthalmol 1987;15:52-6.